The post Top Bullish Predictions for XRP, BNB, Solana, Cardano, Tron Align with Fresh Chart Data ⋆ ZyCrypto appeared on BitcoinEthereumNews.com. Advertisement &The post Top Bullish Predictions for XRP, BNB, Solana, Cardano, Tron Align with Fresh Chart Data ⋆ ZyCrypto appeared on BitcoinEthereumNews.com. Advertisement &

Top Bullish Predictions for XRP, BNB, Solana, Cardano, Tron Align with Fresh Chart Data ⋆ ZyCrypto

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
Advertisement

Analysts have begun to share constructive opinions on altcoins as March begins, pointing to improving technical structure and shifting momentum that mirror early stages of prior expansion cycles.

Pseudonymous trader Chain Mind notes that altcoin dominance, primarily XRP, BNB, Solana, Cardano, and Tron, has broken its macro downtrend, with monthly momentum now flipping higher. The analyst argues that similar signals emerged in 2020 before a broad-based rally across altcoins, and that the current setup points to a materially larger rotation.

According to this assessment, the structural shift in dominance is the foundation for what Chain Mind describes as the next major altseason.

Other market observers also shared corroborating data. Nunu highlights that only 5% of altcoins are above their 200-day moving average. This statistic historically reflects washed-out conditions rather than overheating. The analyst also reported obvious whale accumulation in assets such as UNI and BCH, while breakout formations are developing in ASTER, ARB, and APTOS.

Meanwhile, major token unlocks tied to SUI, ENA, and HYPE are approaching, events that often reshape liquidity dynamics. Ethereum dominance is also rolling over, a development that some analysts interpret as capital gradually rotating from large caps into higher-beta names.

Advertisement
 

CryptoSymbiiote adds that altcoins have rebounded from a year-long support trend line, projecting the next three to six months as a potentially explosive window for returns if momentum persists.

Despite the optimism, broad market metrics still classify the environment as Bitcoin season. CoinMarketCap’s Altcoin Index reads 36 out of 100, up from 31 last week and 32 last month, but well below the yearly high of 78 recorded on September 20, 2025.

Furthermore, there is a notable dispersion in altcoin performance. Over the past 90 days, RIVER has surged 250.19%, followed by PIPPIN at 155.07% and KITE at 149.69%, while larger assets such as TRX have gained less than 1%.

Market watchers believe that sustained improvement in dominance and breadth will determine whether March marks the beginning of a broader altcoin resurgence.

Source: https://zycrypto.com/top-bullish-predictions-for-xrp-bnb-solana-cardano-tron-align-with-fresh-chart-data/

Market Opportunity
Binance Coin Logo
Binance Coin Price(BNB)
$629.97
$629.97$629.97
+0.31%
USD
Binance Coin (BNB) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09